Ads
related to: macular degeneration versus glaucoma treatment
Search results
Results From The WOW.Com Content Network
The incidence of age-related macular degeneration and its associated features increases with age and is low in people <55 years of age. [101] Smoking is the strongest modifiable risk factor. [102] As of 2008, age-related macular degeneration accounts for more than 54% of all vision loss in the white population in the US. [103]
Angle-closure glaucoma should be considered if there is painful loss of vision with a red eye, nausea or vomiting. [4] The eye pressure will be very high typically greater than 40 mmHg. [ 5 ] Emergent laser treatment to the iris may prevent blindness.
Treatment typically includes prescription of eye drops, medication, laser treatment or surgery. [1] [9] The goal of these treatments is to decrease eye pressure. [2] Glaucoma is a leading cause of blindness in African Americans, Hispanic Americans, [10] [11] and Asians. [12]
Argon, krypton, dye and diode lasers have been used with varying levels of energy to try to prevent age-related macular degeneration by eliminating drusen. A Cochrane review published in 2015 found that while laser treatment reduces drusen, there is no difference from placebo at 2 years with respect to preventing vision loss. [5]
In other words, uveitis diseases tend to be classified by their anatomic location in the eye (e.g. uveal tract, retina, or lens), as well as can create complication that can cause cataracts, glaucoma, retinal damage, age-related macular degeneration or diabetic retinopathy. [71]
Age-Related Macular Degeneration is a degenerative maculopathy associated with progressive sight loss. It is characterised by changes in pigmentation in the Retinal Pigment Epithelium, the appearance of drusen on the retina of the eye and choroidal neovascularization. AMD has two forms; 'dry' or atrophic/non-exudative AMD, and 'wet' or ...